<DOC>
	<DOCNO>NCT01899612</DOCNO>
	<brief_summary>Many postmenopausal woman suffer vaginal symptom dryness , itching , painful intercourse . The underlie pathology unknown . Since symptom comparable find infectious vaginitis reproductive life stage , investigator hypothesize vaginal milieu symptomatic postmenopausal woman comparable inflammation vaginitis . The investigator therefore study vaginal cytokine symptomatic asymptomatic postmenopausal woman .</brief_summary>
	<brief_title>Vaginal Inflammation Markers Postmenopausal Women With Without Symptoms Vaginal Inflammation</brief_title>
	<detailed_description>Background Vulvovaginal irritation frequent complaint among postmenopausal woman hormone therapy . Common symptom include pruritus . Patients describe irritation similar vulvovaginal candidiasis reproductive year . Clinical improvement see estrogen therapy . Most clinician attribute symptom vaginal dryness secondary estrogen deficiency . However , underlie pathophysiology clinical entity well define . Since cytokine show play significant role pathogenesis infectious vaginitis , evidence suggest estrogen influence cytokine production , postulate estrogen deficiency cause disturbance vaginal cytokine environment similar infectious vulvovaginitis . Studies investigate pathogenesis bacterial vaginosis , vulvovaginal candidiasis , vestibulitis identify change level antibody cytokine vagina process . Donders co-worker perform study look correlation disturbance lactobacillary flora , vaginal pH , interleukin 1beta ( IL-1b ) , interleukin 8 ( IL-8 ) . Menopausal woman exclude study . Vaginal pH , IL-8 , IL-1β concentration increase linearly decrease lactobacilli 4 10 fold . IL-1β concentration closely related decrease lactobacillus , IL-8 concentration closely related positive culture result . Regúlez , Garcia Fernández , co-worker perform study correlate symptom vulvovaginal candidiasis vaginal IgE level . Patients clinically overt vulvovaginal candidiasis classical symptomatology regardless whether yeast mycelium identify fresh smear culture high IgE level vagina asymptomatic carrier uninfected control . This variation host response propose one mechanism woman vulvovaginal candidiasis experience symptom . This concept imbalance TH1 TH2 cell reactivity preference latter suggest Puccetti , Romani Bistoni . In contrary finding Regúlez , Garcia Fernández co-worker , Fidel , Ginsburg , co-worker study vaginal-associated immunity woman recurrent vulvovaginal candidiasis find Th-1 type response increase . This area certainly controversial require investigation . Since IL-6 suggest one cytokine involve Th-2 immediate-type hypersensitivity response , interest study whether level increase patient symptomatology . Foster Hasday compare level IL-1b , tumor necrosis factor-alpha ( TNF-a ) perineal biopsy woman vulvar vestibulitis pain-free subject , find increase cytokine former case . Estrogen show influence cytokine activity reproductive tract . García-Velasco Arici publish review article chemokines human reproduction . In article , clinical relevance chemokines normal human reproductive event ovulation , menstruation , implantation summarize . There however little information relevance vaginal physiology . This consistent little information topic vaginal physiology literature . A study Franklin , Kutteh variation immunoglobulin , cytokine cervical mucus twelve woman oral contraceptive ( OCs ) , fifteen naturally cycle woman show definite influence exogenous endogenous hormone level . Cervical IgA , IL-1b level woman take Ortho Novum 777® parallel increase dosage oral norethindrone , level decrease discontinuation oral contraceptive . Cervical IL-1b , IL-10 peak ovulation natural cycle . Cervical mucus IL-1b level find correlate directly change estrogen level natural cycle . Vaginal cytokine level investigate study . Al-Harth , co-worker measure cervicovaginal IL-1b , IL-4 , IL-6 , IL-8 , IL-10 , interferon-gamma ( INF-gamma ) , transform growth factor-beta ( TGF-b ) , tumor necrosis factor-alpha ( TNF-a ) , macrophage inflammatory protein-1alpha ( MIP-1a ) TNG receptor II ( TNFR II ) follicular , luteal phase ovulatory cycle six premenopausal woman . Cervicovaginal IL-1b , IL-6 find vary level throughout ovulatory cycle . Both IL-1b , IL-6 5-fold high follicular phase luteal phase . Other cervicovaginal cytokine level alter two phase . Plasma IL-8 level high follicular luteal phase . The investigator ' hypothesis postmenopausal estrogen deficiency cause change cytokine level vagina similar find vaginal candidiasis bacterial vaginosis . A common cytokine etiology account similarity symptomatology infectious vaginitis postmenopausal vaginal irritation . Unpublished preliminary data study do premenopausal woman Ballagh co-operating Howard Georgeanna Jones Institute Reproductive Medicine , Department Obstetrics Gynecology , Eastern Virginia Medical School , Norfolk , Virginia , USA , show mean level vaginal IL-1b IL-8 , measure ELISA , high luteal phase follicular phase naturally cycle woman . The median level IL-1b high luteal phase follicular phase IL-8 high follicular phase luteal phase . These result show vaginal interleukin environment varies throughout menstrual cycle another . Women oral contraceptive pill increase mean level vaginal IL-1b , IL-8 compare naturally cycle woman . These data , though preliminary , support theory steroid hormone may play role regulation vaginal cytokine level . Objective The principal goal pilot study determine correlation postmenopausal vulvovaginal irritative symptom vaginal interleukin level . Cytokines evaluate vaginal lavage include IL-1β , IL-6 , IL-8 TNF-α . Plasma interleukin level assess concurrently , compare vaginal level ensure vaginal level obtain result contamination plasma transudate . This study think basis future randomise control trial involve treatment symptomatic menopausal woman investigation whether resolution symptom e.g . estrogen DHEA therapy associate decrease interleukin level . Methods Screening Investigations ( visit 1 ) : History physical examination Vaginal pH , KOH prep , whiff test , wet prep Trichomonas vaginalis Cervical sample Neisseria gonorrhea &amp; Chlamydia trachomatis assay Enrollment Investigations ( visit 2 ) : 1 . Vaginal pH 2 . Vaginal smear Nugent score maturation index 3 . Vaginal wet prep Trichomonas vaginalis 4 . Vaginal KOH prep whiff test 5 . Speculum examination vaginal lavage 6 . Leukocyte count vaginal sample 7 . ELISA serum IL-1b , IL-6 , IL-8 , TNF-a , IgE estradiol 8 . ELISA IL-1b , IL-6 , IL-8 TNF-a IgE vaginal lavage sample</detailed_description>
	<mesh_term>Atrophy</mesh_term>
	<criteria>Age 40 year old At least 1 year history amenorrhea Normal Pap smear within past year Willingness abstain sexual intercourse use overthecounter vaginal product 7 day collection vaginal sample Written inform consent . Exclusion Criteria Administration form oral hormone replacement therapy within 2 month , transdermal vaginal hormone replacement therapy 1 month prior entry study Active vulvovaginal candidiasis , trichomonas vaginitis bacterial vaginitis base vaginal wet prep , pH , whiff test KOH preparation ; Untreated cervical , vaginal vulvar intraepithelial neoplasia ; Active sexually transmit disease include herpes simplex viral infection , gonorrhea Chlamydia Pessaryusers Active treatment tamoxifen , raloxifene form selective estrogen receptor modulators ( SERMs ) ; Undiagnosed vaginal bleeding Hysterectomy Past current history breast cancer , endometrial cancer endometrial hyperplasia , hypertriglyceridemia venous thromboembolism Immunocompromised patient include human immunodeficiency viral infection , chronic glucocorticoid use active treatment immunosuppressive agent</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>menopause</keyword>
	<keyword>vaginal atrophy</keyword>
	<keyword>cytokine</keyword>
	<keyword>IL-1beta</keyword>
	<keyword>IL-6</keyword>
	<keyword>IL-8</keyword>
	<keyword>TNF-alpha</keyword>
</DOC>